Munich, Bavaria, Germany
Chemistry and ADME BD consultant. From Hit to GMP manufacturing.
CRO: GLP analytical services
Development and commercialization of PREDYSTIC®, a novel precision diagnostic tool for RA autoimmune patients. The PREDYSTIC® Infliximab RA Kit is a highly innovative diagnostics system suitable for predicting biological drug (infliximab) response in Rheumatoid Arthritis (RA) patients before treatment initiation.